IQVIA (NYSE:IQV) Sees Unusually-High Trading Volume – Here’s What Happened

IQVIA Holdings Inc. (NYSE:IQV) saw unusually-strong trading volume on Monday . Approximately 872,396 shares traded hands during trading, an increase of 53% from the previous session’s volume of 569,620 shares.The stock last traded at $201.98 and had previously closed at $197.39.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the stock. Evercore ISI decreased their price target on shares of IQVIA from $270.00 to $265.00 and set an “outperform” rating on the stock in a report on Tuesday, October 8th. Robert W. Baird dropped their target price on shares of IQVIA from $213.00 to $212.00 and set a “neutral” rating for the company in a report on Wednesday, December 11th. Stephens started coverage on shares of IQVIA in a report on Friday, December 20th. They issued an “overweight” rating and a $250.00 price objective for the company. StockNews.com lowered shares of IQVIA from a “buy” rating to a “hold” rating in a report on Thursday, November 28th. Finally, Redburn Atlantic assumed coverage on shares of IQVIA in a research report on Monday, October 14th. They set a “buy” rating and a $276.00 price target for the company. Four analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $255.82.

IQVIA Stock Up 1.0 %

The business has a 50-day simple moving average of $202.86 and a two-hundred day simple moving average of $222.14. The company has a debt-to-equity ratio of 1.76, a quick ratio of 0.81 and a current ratio of 0.81. The company has a market capitalization of $36.18 billion, a price-to-earnings ratio of 26.16, a PEG ratio of 2.05 and a beta of 1.48.

Hedge Funds Weigh In On IQVIA

Several hedge funds have recently bought and sold shares of IQV. FMR LLC grew its position in shares of IQVIA by 38.7% in the third quarter. FMR LLC now owns 2,887,342 shares of the medical research company’s stock valued at $684,213,000 after purchasing an additional 804,963 shares during the period. B. Metzler seel. Sohn & Co. Holding AG acquired a new position in shares of IQVIA during the third quarter worth about $147,683,000. JPMorgan Chase & Co. increased its position in shares of IQVIA by 46.2% during the third quarter. JPMorgan Chase & Co. now owns 1,845,711 shares of the medical research company’s stock worth $437,378,000 after acquiring an additional 583,396 shares during the last quarter. Nordea Investment Management AB increased its position in shares of IQVIA by 47.4% during the fourth quarter. Nordea Investment Management AB now owns 1,405,281 shares of the medical research company’s stock worth $277,908,000 after acquiring an additional 452,029 shares during the last quarter. Finally, 1832 Asset Management L.P. increased its position in shares of IQVIA by 472.3% during the second quarter. 1832 Asset Management L.P. now owns 456,335 shares of the medical research company’s stock worth $96,487,000 after acquiring an additional 376,595 shares during the last quarter. 89.62% of the stock is owned by hedge funds and other institutional investors.

About IQVIA

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.